Neuronetics, a firm based in Malvern, Pennsylvania, won FDA approval for its latest NeuroStar transcranial magnetic stimulation therapy system. Approved in the U.S. for treating depression in patients who have tried at least one antidepressant drug, the new system has the major benefit of offering the same therapy during shorter sessions.

Although session duration is decided on by the physician, many sessions can be complete within twenty minutes. This technology relies on focused magnetic fields that don’t seem to cause any serious side effects.

The system features laser positioning and a sensor that feels the contact pressure of the magnetic field generator against the head, helping to get therapy sessions started quickly and with little discomfort.

The majority of people who benefited from treatment with NeuroStar experienced clinically meaningful, long-lasting improvement.

Read more: New NeuroStar Transcranial Magnetic Stimulation Therapy System for Depression Cleared by FDA | Medgadget

Don’t forget to share this via , Google+, Pinterest, LinkedIn, Buffer, , Tumblr, Reddit, StumbleUpon and Delicious.

Published by Mike Rawson

Mike Rawson has recently re-awoken a long-standing interest in robots and our automated future. He lives in London with a single android - a temperamental vacuum cleaner - but is looking forward to getting more cyborgs soon.

Leave a comment

Your email address will not be published. Required fields are marked *


New NeuroStar Transcranial Magnetic Stimulation Therapy System for Dep…

by Mike Rawson time to read: 1 min
Hi there - can I help you with anything?
[Subscribe here]
More in IoT, News
3D printed human cartilage
Human cartilage has been successfully 3D printed

3D printers have been causing revolutions in many different fields, with materials as different as food, mud, plastic, and plants....